Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. | Int J Gynecol Pathol | 2022 | 34483300 | PubTator, text mining | PubMed |
| Liver lymphatic anatomy and role in systemic lymphatic disease. | Eur Radiol | 2022 | 34165621 | PubTator, text mining | PubMed |
| Identification of Monocytes Associated with Severe COVID-19 in the PBMCs of Severely Infected Patients Through Single-Cell Transcriptome Sequencing. | Engineering (Beijing) | 2022 | 34150352 | PubTator, text mining | PubMed |
| RAF-MEK-ERK pathway in cancer evolution and treatment. | Semin Cancer Biol | 2022 | 33992782 | PubTator, text mining | PubMed |
| Modeling dynamic correlation in zero-inflated bivariate count data with applications to single-cell RNA sequencing data. | Biometrics | 2022 | 33720414 | PubTator, text mining | PubMed |
| Long-term Management of Panuveitis and Choroidal Mass Associated with Rosai Dorfman Disease with Pegylated Interferon. | Ocul Immunol Inflamm | 2022 | 33683183 | PubTator, text mining | PubMed |
| Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma. | J Liver Cancer | 2021 | 37384270 | PubTator, text mining | PubMed |
| Leveraging biochemical reactions to unravel functional impacts of cancer somatic variants affecting protein interaction interfaces. | F1000Res | 2021 | 36569594 | PubTator, text mining | PubMed |
| Cerebral Infiltrative Lesion and Chronic Clinical Course of the Rosai-Dorfman Disease. | Iran J Child Neurol | 2021 | 36213157 | PubTator, text mining | PubMed |
| FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer. | Front Oncol | 2021 | 35712679 | PubTator, text mining | PubMed |
| Drug resistance in targeted cancer therapies with RAF inhibitors. | Cancer Drug Resist | 2021 | 35582307 | PubTator, text mining | PubMed |
| Inward Outward Signaling in Ovarian Cancer: Morpho-Phospho-Proteomic Profiling Upon Application of Hypoxia and Shear Stress Characterizes the Adaptive Plasticity of OVCAR-3 and SKOV-3 Cells. | Front Oncol | 2021 | 35251951 | PubTator, text mining | PubMed |
| Case Report: Durable Clinical Response to Third-Line Pyrotinib After Resistance to Trastuzumab in a Gastric Cancer Patient. | Front Oncol | 2021 | 35155188 | PubTator, text mining | PubMed |
| Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0). | Front Endocrinol (Lausanne) | 2021 | 35154002 | PubTator, text mining | PubMed |
| Association Between Tumor Mutation Profile and Clinical Outcomes Among Hispanic-Latino Patients With Metastatic Colorectal Cancer. | Front Oncol | 2021 | 35141142 | PubTator, text mining | PubMed |
| Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis. | Front Oncol | 2021 | 35127485 | PubTator, text mining | PubMed |
| Radiomics and Radiogenomics in Evaluation of Colorectal Cancer Liver Metastasis. | Front Oncol | 2021 | 35070948 | PubTator, text mining | PubMed |
| Case Report: An Unusual Course of Angiosarcoma After Lung Transplantation. | Front Immunol | 2021 | 35046948 | PubTator, text mining | PubMed |
| Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl ester as ATP-competitive inhibitors of BRAF: A bioinformatics study. | Curr Res Struct Biol | 2021 | 35028596 | PubTator, text mining | PubMed |
| The mechanism of Raf activation through dimerization. | Chem Sci | 2021 | 35003591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=30